Browsing Tag
Alembic Pharmaceuticals Limited
3 posts
Alembic Pharmaceuticals gains three USFDA approvals in oncology and neurology, but can these launches offset U.S. pricing pressures?
Alembic Pharmaceuticals secures USFDA approvals in oncology and neurology, but can these launches drive U.S. revenue growth? Read the full analysis.
Alembic Pharmaceuticals secures US FDA approval for Ketorolac Tromethamine injectable as generic to Roche’s Toradol
Alembic Pharmaceuticals wins US FDA approval for Ketorolac Tromethamine injectable, a generic to Roche’s Toradol, expanding its US sterile injectables portfolio.
Alembic Pharmaceuticals clears US FDA inspection at Vadodara bioequivalence facility without observations
Alembic Pharmaceuticals clears US FDA inspection at Vadodara bioequivalence facility with zero observations, strengthening its generics pipeline and regulatory track record.